Bilaketaren emaitzak - Jeremy R. Graff

Findu emaitzak
  1. 1
    eIF-4E expression and its role in malignancies and metastases

    eIF-4E expression and its role in malignancies and metastases nork Arrigo De Benedetti, Jeremy R. Graff

    Argitaratua 2004
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development

    Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development nork Jerry Pelletier, Jeremy R. Graff, Davide Ruggero, Nahum Sonenberg

    Argitaratua 2015
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Targeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy

    Targeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy nork Jeremy R. Graff, Bruce W. Konicek, Julia H. Carter, Eric G. Marcusson

    Argitaratua 2008
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

    Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. nork James G. Herman, Jeremy R. Graff, Sanna Myöhänen, B D Nelkin, S B Baylin

    Argitaratua 1996
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression

    Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression nork Jeremy R. Graff, Edward Gabrielson, Hiraoki Fujii, Stephen B. Baylin, James G. Herman

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Hypomethylation of pericentromeric DNA in breast adenocarcinomas

    Hypomethylation of pericentromeric DNA in breast adenocarcinomas nork Ajita Narayan, Weizhen Ji, Xian-Yang Zhang, Aizen J. Marrogi, Jeremy R. Graff, Stephen B. Baylin, Melanie Ehrlich

    Argitaratua 1998
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers

    Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers nork Rebecca Lock, Rachel Ingraham, Ophélia Maertens, Abigail L. Miller, Nelly Weledji, Eric Legius, Bruce M. Konicek, S. Betty Yan, Jeremy R. Graff, Karen Cichowski

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors

    Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors nork Jessica K. Altman, Amy Szilard, Bruce W. Konicek, Philip W. Iversen, Barbara Kroczyńska, Heather Glaser, Antonella Sassano, Eliza Vakana, Jeremy R. Graff, Leonidas C. Platanias

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Expression of Group IIA Secretory Phospholipase A2 Is Elevated in Prostatic Intraepithelial Neoplasia and Adenocarcinoma

    Expression of Group IIA Secretory Phospholipase A2 Is Elevated in Prostatic Intraepithelial Neoplasia and Adenocarcinoma nork Jiazhong Jiang, Blake Lee Neubauer, Jeremy R. Graff, Márcio F. Chedid, James E. Thomas, Neal W. Roehm, Shaobo Zhang, George J. Eckert, Michael O. Koch, John N. Eble, Liang Cheng

    Argitaratua 2002
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression

    Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression nork Lisa M. McGregor, Bryan K. McCune, Jeremy R. Graff, Philip R. McDowell, Katherine E. Romans, George D. Yancopoulos, Douglas W. Ball, Stephen B. Baylin, Barry D. Nelkin

    Argitaratua 1999
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma

    Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma nork Julia H. Carter, James A. Deddens, Nelson Reed Spaulding, Denise Lucas, Bruce M. Colligan, Thomas G. Lewis, Elyse Hawkins, Jordan Jones, Jackson O. Pemberton, Larry E. Douglass, Jeremy R. Graff

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression

    Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression nork Jeremy R. Graff, Bruce W. Konicek, Ann M. McNulty, Zejing Wang, Keith A. Houck, Sheryl Allen, Jonathan Paul, Ahed Hbaiu, Robin G. Goode, George E. Sandusky, Robert L. Vessella, Blake Lee Neubauer

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes

    Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes nork Christos G. Gkogkas, Arkady Khoutorsky, Ruifeng Cao, Seyed Mehdi Jafarnejad, Masha Prager‐Khoutorsky, N. Giannakas, Archontia Kaminari, Apostolia Fragkouli, Karim Nader, Theodore J. Price, Bruce W. Konicek, Jeremy R. Graff, Athina Tzinia, Jean‐Claude Lacaille, Nahum Sonenberg

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation

    Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation nork Anissa Chan, Adria Bykowski Jonas, Xiaohong Qiu, Nadine Ottoson, Richard M. Walsh, Keith Gorden, Ben Harrison, Peter Maimonis, Steven Leonardo, Kathleen Ertelt, Michael E. Danielson, Kyle S. Michel, Mariana I. Nelson, Jeremy R. Graff, Myra L. Patchen, Nandita Bose

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma

    Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma nork James G. Herman, Asad Umar, Kornélia Polyák, Jeremy R. Graff, Nita Ahuja, Jean–Pierre J. Issa, Sanford D. Markowitz, James K. V. Willson, Stanley R. Hamilton, Kenneth W. Kinzler, Michael Kane, Richard D. Kolodner, Bert Vogelstein, Thomas A. Kunkel, Stephen B. Baylin

    Argitaratua 1998
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases

    Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases nork Bruce W. Konicek, Jennifer R. Stephens, Ann M. McNulty, Nathaniel Robichaud, Robert B. Peery, Chad A. Dumstorf, Michele Dowless, Philip W. Iversen, Stephen H. Parsons, Karen E. Ellis, Denis McCann, Jerry Pelletier, Luc Furic, Jonathan M. Yingling, Louis F. Stancato, Nahum Sonenberg, Jeremy R. Graff

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival

    eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival nork Jeremy R. Graff, Bruce W. Konicek, Rebecca L. Lynch, Chad A. Dumstorf, Michele Dowless, Ann M. McNulty, Stephen H. Parsons, Leslie H. Brail, Bruce M. Colligan, Jonathan W. Koop, Bernadette M. Hurst, James A. Deddens, Blake Lee Neubauer, Louis F. Stancato, Harry W. Carter, Larry E. Douglass, Julia H. Carter

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts

    The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer... nork Jeremy R. Graff, Ann M. McNulty, Kimberly R. Hanna, Bruce W. Konicek, Rebecca L. Lynch, Spring N. Bailey, Crystal Banks, Andrew Capen, Robin L. Goode, Jason E. Lewis, Lillian Sams, Karen Huss, Robert M. Campbell, Philip W. Iversen, Blake Lee Neubauer, Thomas J. Brown, Luna Musib, Sandaruwan Geeganage, Donald Thornton

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

    LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft mo... nork S. Betty Yan, Victoria L. Peek, Rose T. Ajamie, Sean G. Buchanan, Jeremy R. Graff, Steven A. Heidler, Yu‐Hua Hui, Karen Huss, Bruce W. Konicek, Jason R. Manro, Chuan Shih, Julie Stewart, Trent R. Stewart, Stephanie L. Stout, Mark Uhlik, Suzane L. Um, Yong Wang, Wenjuan Wu, Lei Yan, Wei Yang, Boyu Zhong, Richard A. Walgren

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity

    Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity nork Robert M. Campbell, Bryan D. Anderson, Nathan A. Brooks, Harold B. Brooks, Edward M. Chan, Alfonso de Dios, Raymond Gilmour, Jeremy R. Graff, Enrique Jambrina, Mary M. Mader, Denis McCann, Songqing Na, Stephen H. Parsons, Susan E. Pratt, Chuan Shih, Louis F. Stancato, James J. Starling, Courtney M. Tate, Juan A. Velasco, Yong Wang, Xiang S. Ye

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: